Document Detail

A Translational Paradigm for the Preclinical Evaluation of the Stroke Neuroprotectant Tat-NR2B9c in Gyrencephalic Nonhuman Primates.
MedLine Citation:
PMID:  23035045     Owner:  NLM     Status:  In-Data-Review    
Over decades, all attempts to translate acute stroke neuroprotectants from discovery in lower-order species to human clinical use have failed. This raised concerns about the predictive validity of preclinical studies in animals for outcomes in human stroke trials. To bridge this translational gap, we used high-order gyrencephalic nonhuman primates subjected to an experimental protocol that mimicked that of a corresponding, separately reported, clinical trial in which the human subjects underwent endovascular cerebral aneurysm repair. Both placebo-controlled studies tested neuroprotection by Tat-NR2B9c, a prospective therapeutic compound, in anesthetized subjects. Embolic strokes were produced by small intra-arterial emboli caused by the endovascular procedure. We show that primates treated with Tat-NR2B9c after the onset of embolic strokes exhibited significantly reduced numbers and volumes of strokes, as visualized by diffusion- and T2-weighted magnetic resonance imaging. These results correctly anticipated the outcome of the corresponding human trial, thus validating this study design as a predictor of neuroprotective efficacy in humans. This strategy may facilitate the evaluation of promising neuroprotectants before undertaking similar studies in human subjects.
Douglas J Cook; Lucy Teves; Michael Tymianski
Related Documents :
12113925 - The influence of depressive state features on trait measurement.
18601305 - Efficacy and tolerability of pharmacotherapies for borderline personality disorder.
24846785 - The many faces of malingering and participant response strategies: new methodologies in...
23439195 - Use of the womac questionnaire in mumbai and the challenges of translation and cross cu...
24993075 - Effect of swallowing training on dysphagia and depression in postoperative tongue cance...
20543275 - Use of immersive virtual reality for treating anger.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Science translational medicine     Volume:  4     ISSN:  1946-6242     ISO Abbreviation:  Sci Transl Med     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101505086     Medline TA:  Sci Transl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  154ra133     Citation Subset:  IM    
Toronto Western Hospital Research Institute, Toronto, Ontario M5T 2S8, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  "What great creation".
Next Document:  Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangio...